Wegovy 0.5mg Semaglutide Subcutaneous Injection SD

Wegovy 0.5mg Semaglutide Subcutaneous Injection SD contains semaglutide, a glucagon-like peptide-1 receptor agonist, commonly known as a GLP-1 receptor agonist. It is a prescription-only subcutaneous injection medicine intended for use under the supervision of a licensed healthcare professional.

Wegovy is a once-weekly injectable semaglutide medicine. The 0.5mg strength is generally used during the early dose-escalation stage after the initial starting dose, depending on treatment plan, tolerability, and healthcare professional assessment. Dose changes should only be made according to medical advice.

This product listing refers to 0.5mL × 2 pens / 2 single-dose pens.

Product Information

• Product Name: Wegovy 0.5mg Semaglutide Subcutaneous Injection SD
• Japanese Name: ウゴービ皮下注 0.5mg SD
• Chinese Name: Wegovy 0.5mg 司美格魯肽／索瑪魯肽皮下注射液 SD（2 支裝）
• Active Ingredient: Semaglutide
• Strength: 0.5mg
• Volume: 0.5mL
• Pack Size: 2 pens
• Dosage Form: Subcutaneous injection pen
• Route of Administration: Subcutaneous
• Drug Class: GLP-1 receptor agonist
• Brand Owner: Novo Nordisk
• Product Type: Prescription medicine
• Use: Use only as directed by a licensed healthcare professional

What Is Wegovy 0.5mg Semaglutide Subcutaneous Injection SD?

Wegovy 0.5mg Semaglutide Subcutaneous Injection SD is a prefilled single-dose injection pen containing semaglutide for subcutaneous administration. Semaglutide belongs to the GLP-1 receptor agonist class of medicines. GLP-1 receptor agonists act on receptors involved in appetite regulation, satiety signaling, gastric emptying, and metabolic control.

Wegovy is typically prescribed as part of a comprehensive medical weight-management plan that may include diet, physical activity, behavioural changes, and ongoing medical monitoring. It should only be used when assessed and prescribed by a healthcare professional.

This medicine should not be used without a prescription or professional medical supervision.

Key Features

Wegovy 0.5mg Semaglutide Subcutaneous Injection SD is known for:

• Contains semaglutide 0.5mg
• Early dose-escalation strength in many treatment schedules
• 0.5mL × 2 pens pack format
• Subcutaneous injection pen
• Once-weekly administration as directed
• GLP-1 receptor agonist medicine
• Used as part of a doctor-supervised treatment plan
• Manufactured by Novo Nordisk
• Prescription-only medicine
• Intended for healthcare professional-directed use

About Semaglutide

Semaglutide is a GLP-1 receptor agonist. It acts on GLP-1 receptors involved in metabolic regulation and appetite-related pathways.

Under healthcare professional guidance, semaglutide may help support:

• Appetite regulation
• Satiety and fullness signaling
• Reduced food intake as part of a treatment plan
• Slower gastric emptying
• Weight-management care
• Metabolic health monitoring

Suitability and response vary between individuals and depend on medical history, current medicines, treatment goals, and healthcare professional assessment.

Dose Strength Information

The 0.5mg strength is commonly used after the initial 0.25mg starting dose as part of a gradual dose-escalation schedule. It is not usually considered the full maintenance dose unless specifically directed by a healthcare professional.

A doctor may review:

• Treatment suitability
• Dose-escalation schedule
• Digestive tolerability
• Treatment response
• Current medications
• Weight-management goals
• Blood glucose status
• Medical history and contraindications

Patients should not increase, decrease, skip, restart, or stop doses without medical advice.

How to Use Wegovy 0.5mg Semaglutide Subcutaneous Injection SD

Use exactly as directed by your doctor, pharmacist, or healthcare provider.

General administration guidance may include:

• Inject under the skin as prescribed.
• Common injection areas may include abdomen, thigh, or upper arm.
• Use once weekly if prescribed.
• Use on the same day each week where possible.
• Each pen is single-dose use only.
• Do not inject into a vein or muscle.
• Rotate injection sites.
• Do not share injection pens with others.
• Follow the official instructions for use supplied with the medicine.

Always read the patient information leaflet and follow healthcare professional guidance.

Who May Be Prescribed Wegovy 0.5mg Semaglutide Subcutaneous Injection SD?

Wegovy 0.5mg may be prescribed to suitable adult patients as part of a healthcare professional-supervised treatment plan.

A healthcare professional may assess:

• Body weight and BMI criteria
• Weight-related health conditions
• Medical history
• Current medications
• Previous GLP-1 medicine use
• Digestive system conditions
• Pancreatitis risk
• Gallbladder disease risk
• Kidney function
• Diabetes status
• Pregnancy or breastfeeding status
• Ability to safely use an injectable medicine

This product is not suitable for everyone and should only be used after medical assessment.

Important Safety Information

Before using Wegovy 0.5mg Semaglutide Subcutaneous Injection SD, tell your healthcare provider if you:

• Have a history of pancreatitis
• Have gallbladder problems
• Have severe stomach or intestinal disease
• Have kidney disease
• Have liver disease
• Have diabetes or use diabetes medication
• Have diabetic retinopathy
• Have a history of thyroid tumors or endocrine disorders
• Are pregnant, planning pregnancy, or breastfeeding
• Have allergies to semaglutide or any ingredient in the injection
• Are taking any prescription, over-the-counter, or herbal medicines

Possible Side Effects

Common side effects may include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal pain or discomfort
• Indigestion
• Bloating
• Headache
• Fatigue
• Dizziness
• Injection site reaction

Serious side effects may occur and require medical attention.

Seek medical help immediately if you experience:

• Severe or persistent abdominal pain
• Severe vomiting or dehydration
• Signs of pancreatitis
• Signs of gallbladder problems
• Allergic reaction
• Severe hypoglycemia symptoms, especially if used with diabetes medicine
• Vision changes
• Neck lump, difficulty swallowing, or persistent hoarseness

Storage

Store according to the product package and pharmacist instructions.

General storage recommendations:

• Keep in original packaging.
• Store refrigerated if required by product instructions.
• Do not freeze.
• Protect from heat and direct sunlight.
• Keep out of reach of children and pets.
• Do not use after the expiry date.
• Dispose of used pens safely according to local guidance.

Important Notes

• Wegovy 0.5mg Semaglutide Subcutaneous Injection SD is a prescription medicine.
• This listing refers to 0.5mL × 2 pens.
• Use only under healthcare professional supervision.
• Do not share injection pens.
• Do not use for casual or cosmetic weight loss without medical indication.
• Dose adjustment should only be made by a healthcare professional.
• It should be used as part of a comprehensive medical weight-management plan.
• Individual response and tolerability may vary.

Disclaimer

This product page is for general product information only and does not replace professional medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Wegovy is a prescription medicine. Use only under the supervision of a licensed healthcare professional. This product information is for reference only and does not replace medical advice, diagnosis, or treatment.